Board of Strides Pharma Science approves appointment of CEO and MD

At meeting held on 08 January 2020

The Board of Strides Pharma Science at its meeting held on 08 January 2020 has approved the following -

Appointment of Dr. R Ananthanarayanan (DIN: 02231540) as Chief Executive Officer & Managing Director of the Company effective 09 January 2020, for a period of 5 years, subject to approval of the Members of the Company. Further, he is also appointed as Key Managerial Personnel of the Company effective 09 January 2020.

2) Re-designation of Arun Kumar (DIN: 00084845) as Executive Director effective 09 January 2020.

Powered by Capital Market - Live News